{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"ProQR Therapeutics N.V."},"Symbol":{"label":"Symbol","value":"PRQR"},"Address":{"label":"Address","value":"ZERNIKEDREEF 9, LEIDEN, 2333 CK, Netherlands"},"Phone":{"label":"Phone","value":"+31 881667000"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa."},"CompanyUrl":{"label":"Company Url","value":"https://www.proqr.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Daniel Anton de Boer","title":"Chief Executive Officer & Executive Director"},{"name":"Gerard J. Platenburg","title":"Chief Scientific Officer & Executive Director"},{"name":"Sheila Sponselee","title":"Chief Operations & People Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}